NIH views antioxidants in fruit, veggies and red wine as future chemo treatments; Qatar boosts stem cell research investment;

Cancer

> Antioxidants found in fruit, veggies and red wine kill a wide range of cancer cells and could form the basis of an improved crop of chemotherapy treatments, NIH researchers determined. Story

> Brain tumor cells infected with a cancer-killing virus warn other tumor cells by releasing a special protein alarm. This allows those other cells to defend themselves, researchers at The Ohio State University Comprehensive Cancer Center discovered. Release

> The loss of the BRG1 gene, a tumor suppressor, leaves lung cancer cells resistant to hormones including retinoic acid and steroids, researchers at the Bellvitge Institute for Biomedical Research in southern Spain have found. Release

Stem Cell Research

> The Qatar Foundation for Education, Science and Community Development and Hamad Medical Corp., the Persian Gulf state's main hospital network, will invest in additional studies using stem cells to treat cancer, Gulf News reports. Story

> Researchers failed in their attempt to use high doses of chemotherapy plus a stem cell transplant containing patients' own stem cells to cure their HIV. A similar procedure worked in another patient using an outside donor. Story

Genetics

> Washington State University is hiring a substantial number of geneticists as part of a $15 million plan to build a research program armed with 135 pharmaceutical scientists, The Seattle Times reports. Story

> Stanford University geneticist Michael Snyder let colleagues sequence his DNA and track thousands of genetic markers in his blood over 14 months to help further the science of personalized medicine, the Los Angeles Times reports. Story

And Finally …

> Male mice born with an extra female chromosome have significantly higher sex drives than counterparts with a typical chromosome pattern, according to new research. Story

Suggested Articles

Removing the IRE1-alpha gene from beta cells in mouse models of Type 1 diabetes restored normal insulin production, scientists found.

Selectively targeting TGF-beta1 with Scholar Rock's SRK-181 overcame primary resistance to checkpoint inhibitor therapy in mice.

Enhertu produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients in a phase 1 trial.